Identifying Patients in Risk of Post-operative Complications Using PACU Discharge Criteria
Launched by RIGSHOSPITALET, DENMARK · Dec 4, 2019
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
Patients undergoing esophageal resection and pancreaticoduodenectomy are at high risk of developing complications after surgery. Described patient groups are monitored for at least 24 hours in PACU before returning to the ward.
In Denmark physiological parameters are assessed in the PACU every hour until discharge using the DASAIM discharge criteria (A modified Aldrete score).
The PACU discharge score is calculated on parameters including sedation, respiratory rate, saturation, systolic blood pressure, puls, physical capability (if epidural or spinal anesthesia), pain in rest, nausea, diu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Elective surgery
- • Pancreaticoduodenectomy (KJLC30)
- • Transthoracic esophageal resection without interposition (KJCC10)
- Exclusion Criteria:
- • Patients not expected to be able to cooperate
- • Patients not cognitive well (Mini Mental State Examination \< 24)
- • Pacemaker
- • Patients with allergies including band aid, plastic and silicone
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Trial Officials
Eske K Aasvang, Dr. Med.
Study Chair
Rigshospitalet, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials